H. Fex
Impact in
-
- Carbohydrate Chemistry and Synthesis
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Click Chemistry and Applications
Papers in
-
- Bioactive Compounds and Antitumor Agents 1
- Co-authors
- T. LinderotB. HögbergTh. RosenbergBjörn HögbergE. DiczfalusyH. PalmstiernaP. KneipBengt Borgström
- Journals
- Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (12 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Urology (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
H. Fex
16 papers receiving 375 citations
Peers
Comparison fields: 5 of 85
- Biochemistry 34
- Organic Chemistry 107
- Molecular Biology 182
- Endocrinology, Diabetes and Metabolism 41
- Oncology 57
Countries citing papers authored by H. Fex
This map shows the geographic impact of H. Fex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Fex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Fex more than expected).
Fields of papers citing papers by H. Fex
This network shows the impact of papers produced by H. Fex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Fex. The network helps show where H. Fex may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Fex, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 22 | |
| 2 | 2003 | 39 | |
| 3 | 2002 | 28 | |
| 4 | 1984 | 10 | |
| 5 | 1959 | 4 | |
| 6 | 1959 | 23 | |
| 7 | 1959 | 12 | |
| 8 | 1959 | 3 | |
| 9 | 1959 | 34 | |
| 10 | 1959 | 15 | |
| 11 | 1958 | 18 | |
| 12 | 1953 | 38 | |
| 13 | 1953 | 41 | |
| 14 | 1953 | 54 | |
| 15 | 1953 | 13 | |
| 16 | 1953 | 78 |
About H. Fex
H. Fex is a scholar working on Clinical Biochemistry, Toxicology, Organic Chemistry, Oncology and Polymers and Plastics, having authored 16 papers that have together received 432 indexed citations. Recurring topics across this work include Organometallic Compounds Synthesis and Characterization (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Inorganic and Organometallic Chemistry (2 papers), Metal complexes synthesis and properties (2 papers), Diet, Metabolism, and Disease (2 papers), Melanoma and MAPK Pathways (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Biochemistry (34 citations), Organic Chemistry (107 citations), Molecular Biology (182 citations), Endocrinology, Diabetes and Metabolism (41 citations) and Oncology (57 citations). H. Fex has collaborated with scholars based in United States and Germany. Frequent co-authors include T. Linderot, B. Högberg, Th. Rosenberg, Björn Högberg, E. Diczfalusy, H. Palmstierna, P. Kneip, Bengt Borgström, Klas‐Bertil Augustinsson and Taro Kazuno. Their work appears in journals such as Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry, Bioorganic & Medicinal Chemistry Letters and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.